Kyowa Hakko's Setria® Glutathione Receives Regulatory Approval in Chile

Setria® Glutathione Approved for Sale in Chile

Kyowa Hakko, a well-respected leader in health ingredient innovation, made an exciting announcement about the successful registration of a supplement featuring its branded ingredient, Setria® Glutathione, in Chile. This news comes as a breakthrough for the product's availability in South America, marking the first time that a finished product containing Setria received formal approval from the Secretaría Regional Ministerial (SEREMI) de Salud, Chile's health authority. The supplement is developed by Nutrapharm and contains 500 mg of Setria® Glutathione, a clinically researched and patented antioxidant known for its role in supporting cellular and mitochondrial health.

The significance of this approval cannot be overstated, as it not only represents a major achievement for Kyowa Hakko but also highlights the potential of Chile's growing dietary supplement market. As consumers become increasingly interested in science-backed products, the demand for high-quality supplements is on the rise. Gerardo Sanchez, CEO of Nutrapharm, noted that the Chilean supplement market continues to mature, reflecting a waning interest in products that lack scientific evidence. This latest product offers Chilean consumers an effective tool for promoting wellness in a fast-paced world.

Chile's newly approved Setria® Glutathione supplement is poised to contribute to the country's ongoing journey toward health and wellness solutions. Supporting a broad spectrum of health categories, the ingredient is used in products targeting healthy aging, detoxification, women’s health, and sports nutrition. Rather than focusing on claims that may lack solid grounding, the application of clinically studied ingredients like Setria can help build consumer trust and result in better health outcomes.

Carmen Rodriguez, RD Director for Nutrapharm, commented on the importance of quality and transparency in the supplement industry, highlighting that SEREMI’s approval validates their commitment to these principles. The launch of this product reflects both companies' aspirations to equip consumers with meaningful health benefits through quality supplements backed by research.

Since its inception, Setria® Glutathione has been embraced across various markets including North America, Europe, and Asia, where it has established itself as a go-to option for health-conscious consumers seeking a reliable source of glutathione. Kentucky-based Kyowa Hakko has a strong legacy in fermentation technology and biotechnology, pioneering the production of premium ingredients that emphasize purity and efficacy, and the new approval in Chile signifies an expansion in the product’s market presence.

As a company driven by sustainability and shared value, Kyowa Hakko and Nutrapharm are gearing up to take full advantage of this recent development. Companies interested in incorporating Setria into their product lines can find more information at SetriaGlutathione.com. With a history spanning over 75 years, Kyowa Hakko continues to lead through innovation, striving to enhance health and well-being globally.

In a world continuously challenged by stress and lifestyle-related health issues, the announcement of Setria® Glutathione’s approval in Chile could serve as a catalyst for further advancements in personalized health approaches. As brands gather data and evidence to bolster their product claims, it seems clear that consumers will benefit from ongoing developments in the dietary supplement sector.

About Kyowa Hakko

Kyowa Hakko USA serves as the hub for North and South American operations of Kyowa Hakko Bio Co., Ltd., a distinguished manufacturer known for specialty ingredients in Kirin Holdings' Health Science division. The company’s commitment to quality and innovation continues to carve out new avenues for health products, enhancing both individual and community wellness.

Setria® Glutathione stands as a testament to Kyowa's dedication to advancing health science through ingredient excellence and rigorous research, paving the way for the future of supplements, not just in Chile but worldwide.